dehydrogenase 516 U/L, hemoglobin 12.3 g/dL, leukocyte count 4,300/µL (66% neutrophils, 19% band forms, 1% metamyelocytes, 3% lymphocytes, 11% monocytes), platelet count 130,000/µL, and erythrocyte sedimentation rate 72 mm/h. Chest X-rays were unremarkable, and a set of blood cultures was sterile. A sputum culture yielded Haemophilus influenzae sensitive to ampicillin, and smears and cultures for mycobacteria in one stool and three sputum samples were negative.
The patient was treated with oral amoxicillin for 2 weeks without improvement. Empirical therapy against M. avium complex with clarithromycin, ciprofloxacin, and ethambutol was started; the patient's condition improved dramatically within the next few days, and the fever and diaphoresis disappeared, although cough and sputum production remained unchanged. Three weeks later, a slow-growing nonphotochromogenic mycobacterium, identified as M. nonchromogenicum in a reference laboratory (Centro Nacional de Microbiología, Majadahonda, Madrid, Spain) by biochemical tests and confirmed by polymerase chain reaction-restriction enzyme pattern analysis, was isolated from a blood sample obtained on admission. This microorganism was sensitive to the three drugs administered, and the treatment was continued. Two months later the patient had gained 10 kg, hemoglobin had increased to 13.8 g/dL, the erythrocyte sedimentation rate had decreased to 52 mm/h, and the differential leukocyte count had returned to normal. Antimycobacterial drugs were withheld after 1 year of treatment. Twenty-two months after the diagnosis, the patient is doing well. He is receiving combination antiretroviral therapy, and his CD4-cell count is 128/µL.
M. nonchromogenicum, a slow-growing nonpigmented (Runyon's group III) mycobacterium, belongs to the M. terrae complex, together with M. triviale; it is traditionally considered nonpathogenic. However, it has been involved in a few cases of pulmonary infection (12) and chronic tenosynovitis secondary to puncture wounds (13) , like the related organism M. terrae. In fact, some authors think that M. nonchromogenicum is the true pathogen in the M. terrae complex (13) , and it is possible that some reports have misidentified this organism. This complex was first isolated in soil washings
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Emerging Infectious Diseases Letters from radishes, but it has been found to be ubiquitous in the aquatic environment, including a hospital potable water supply (14) . Unlike osteoarticular infections, which commonly occur in previously healthy people, the scanty reports on pulmonary and disseminated infection by M. terrae complex suggest that either immunosuppression or local predisposing conditions (e.g., tuberculous cavities) are necessary pathogenetic cofactors (15) . To our knowledge, M. nonchromogenicum bacteremia has never been reported before.
No specific DNA probes exist for M. terrae complex, but false-positive reactions with M. tuberculosis complex DNA probes have been described (16) . Isolates are usually resistant to most antituberculosis drugs, with the exception of ethambutol and streptomycin, and susceptible to erythromycin, ciprofloxacin, and sulfonamides.
Only one case of disseminated infection by M. terrae has been described in a patient with advanced HIV infection and positive cultures in blood and bronchoalveolar lavage fluid, but no additional data were provided (9) . Although the isolate we recovered might represent a laboratory contaminant, several pieces of evidence make this possibility very unlikely: lack of alternative explanation for a persistent and progressive clinical picture of 4 months' duration, absence of response to standard antibiotic therapy, negative results in the search for other pathogens, rapid and sustained clinical and laboratory response to drugs active against this strain, clear improvement despite the lack of treatment for other conditions, and absence of other isolates of this pathogen in our hospital despite the large number of samples examined for mycobacteria.
